Are neutrophil/lymphocyte ratio and platelet/lymphocyte ratio associated with prognosis in patients with HER2-positive early breast cancer receiving adjuvant trastuzumab? (Q41544163)
Jump to navigation
Jump to search
scientific article published on May 2015
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Are neutrophil/lymphocyte ratio and platelet/lymphocyte ratio associated with prognosis in patients with HER2-positive early breast cancer receiving adjuvant trastuzumab? |
scientific article published on May 2015 |
Statements
Are neutrophil/lymphocyte ratio and platelet/lymphocyte ratio associated with prognosis in patients with HER2-positive early breast cancer receiving adjuvant trastuzumab? (English)
Mustafa Degirmenci
Arife Ulas
Nilufer Avci
Tugba Kos
Erdem Cubukcu
Omer Fatih Olmez